tirzepatide trial Cardiovascular outcomes of semaglutide and for patients with type 2 diabetes in clinical practice Weight-loss jab Mounjaro trial begins

Intramuscular (IM) injection, by contrast, delivers medication directly into muscle tissue, which has a different vascular supply and absorption profile

Elevated fasting blood sugar or triglycerides: Often discovered through routine bloodwork, sometimes with no other symptoms at all

Semaglutide remains active in your body for about 7 days, so appetite suppression and metabolic benefits continue even with a brief gap

It has been extensively studied for its effects on the brain and body

Dyslipidemia of the metabolic syndrome

The most common reactions we see include slight discomfort where the IV is placed, occasional mild headaches, or a brief flushing sensation during administration